Product: Neurovascular Embolectomy Devices
The neurovascular embolectomy devices segment in the clot management devices market is expected to witness significant growth in the coming years. These devices are used for the removal of blood clots in the neurovascular system, particularly in cases of stroke or other vascular diseases. The increasing prevalence of stroke and other vascular disorders is driving the demand for neurovascular embolectomy devices in hospitals and diagnostic centers.
Product: Percutaneous Thrombectomy Devices
The percutaneous thrombectomy devices segment is also anticipated to experience substantial growth in the clot management devices market. These devices are used for the minimally invasive removal of blood clots in peripheral arteries and veins. The rise in the number of patients with peripheral vascular diseases is boosting the adoption of percutaneous thrombectomy devices in hospitals and diagnostic centers.
End-use: Diagnostic Centers
Diagnostic centers play a crucial role in the clot management devices market as they are responsible for the early detection and diagnosis of vascular disorders. The increasing awareness about the importance of early diagnosis and treatment of blood clots is driving the demand for clot management devices in diagnostic centers. Moreover, the availability of advanced imaging technologies in diagnostic centers is further contributing to the growth of the market.
End-use: Hospitals
Hospitals are the key end-users of clot management devices, accounting for a significant share of the market. The high patient footfall in hospitals, coupled with the increasing number of surgeries and procedures involving clot management devices, is fueling the demand for these devices. Hospitals are also investing in advanced clot management technologies to improve patient outcomes and reduce the risk of complications associated with blood clots.